Global Markets
Directs, Chronic Back Pain - Pipeline Review, H2 2014, provides an
overview of the Chronic Back Pains therapeutic pipeline.
This report provides
comprehensive information on the therapeutic development for Chronic
Back Pain, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type, along with latest
updates, and featured news and press releases. It also reviews key
players involved in the therapeutic development for Chronic Back Pain
and special features on late-stage and discontinued projects.
View Full Report at
http://www.marketresearchreports.biz/analysis/220031
Global Markets
Directs report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The
report is built using data and information sourced from Global
Markets Directs proprietary databases, Company/University websites,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources,
put together by Global Markets Directs team. Drug profiles/records
featured in the report undergoes periodic updation following a
stringent set of processes that ensures that all the profiles are
updated with the latest set of information. Additionally, processes
including live news & deals tracking, browser based alert-box and
clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
Download Detail
Report With Complete TOC at
http://www.marketresearchreports.biz/sample/sample/220031
The report enhances
decision making capabilities and help to create effective counter
strategies to gain competitive advantage. It strengthens R&D
pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Note*: Certain
sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- The report
provides a snapshot of the global therapeutic landscape of Chronic
Back Pain
- The report reviews
key pipeline products under drug profile section which includes,
product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews
key players involved in the therapeutics development for Chronic Back
Pain and enlists all their major and minor projects
- The report
summarizes all the dormant and discontinued pipeline projects
- A review of the
Chronic Back Pain products under development by companies and
universities/research institutes based on information derived from
company and industry-specific sources
- Pipeline products
coverage based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- A detailed
assessment of monotherapy and combination therapy pipeline projects
- Coverage of the
Chronic Back Pain pipeline on the basis of target, MoA, route of
administration and molecule type
- Latest news and
deals relating related to pipeline products
Reasons to buy
- Provides
strategically significant competitor information, analysis, and
insights to formulate effective R&D development strategies
- Identify emerging
players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage
- Develop strategic
initiatives by understanding the focus areas of leading companies
- Identify and
understand important and diverse types of therapeutics under
development for Chronic Back Pain
- Plan mergers and
acquisitions effectively by identifying key players of the most
promising pipeline
- Devise corrective
measures for pipeline projects by understanding Chronic Back Pain
pipeline depth and focus of Indication therapeutics
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the
therapeutic portfolio by identifying discontinued projects and
understanding the factors that drove them from pipeline
No comments:
Post a Comment